{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:35:00Z","timestamp":1790660100660,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T00:00:00Z","timestamp":1315785600000},"content-version":"vor","delay-in-days":254,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1186\/1532-429x-13-45","type":"journal-article","created":{"date-parts":[[2011,9,13]],"date-time":"2011-09-13T03:04:54Z","timestamp":1315883094000},"page":"45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure"],"prefix":"10.1016","volume":"13","author":[{"given":"DJ","family":"Pennell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Roughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZI","family":"Cabantchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1186\/1532-429X-13-45_bib1","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"23","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1186\/1532-429X-13-45_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron","volume":"123","author":"Carpenter","year":"2011","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10976640600698155","article-title":"Myocardial iron loading in patients with thalassemia major on deferoxamine chelation","volume":"8","author":"Tanner","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3324\/haematol.13845","article-title":"T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman","volume":"94","author":"Daar","year":"2009","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10976640600698155","article-title":"Myocardial iron loading in patients with thalassemia major on deferoxamine chelation","volume":"8","author":"Tanner","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.2010.08365.x","article-title":"Cardiac magnetic resonance in transfusion dependent thalassaemia: assessment of iron load and relationship to left ventricular ejection fraction","volume":"151","author":"Chouliaras","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-13-45_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3324\/haematol.2010.025510","article-title":"Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study","volume":"96","author":"Marsella","year":"2011","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib8","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib9","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo controlled, double blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib11","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1532-429X-11-20","article-title":"The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study","volume":"11","author":"Berdoukas","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib13","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3324\/haematol.2009.009118","article-title":"Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone","volume":"94","author":"Telfer","year":"2009","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","article-title":"Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance","volume":"127","author":"Anderson","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-13-45_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9343(01)00879-8","article-title":"Heart failure in beta thalassemia: a 5-year follow-up study","volume":"111","author":"Kremastinos","year":"2001","journal-title":"Am J Med"},{"key":"10.1186\/1532-429X-13-45_bib18","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jmri.20915","article-title":"Normalized left ventricular volumes and function in thalassemia major patients with normal myocardial iron","volume":"25","author":"Westwood","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-13-45_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jmri.10332","article-title":"A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload","volume":"18","author":"Westwood","year":"2003","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/1532-429X-13-45_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10976640600572889","article-title":"Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance","volume":"8","author":"Maceira","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1186\/1532-429X-13-45_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0002-9149(02)02381-0","article-title":"Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy","volume":"90","author":"Grothues","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1186\/1532-429X-13-45_bib23","series-title":"Cardiovascular magnetic resonance","article-title":"Assessment of cardiac function","author":"Maceira","year":"2010"},{"key":"10.1186\/1532-429X-13-45_bib24","first-page":"489","article-title":"Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis","volume":"88","author":"Piga","year":"2003","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib25","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","article-title":"Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major","volume":"107","author":"Borgna-Pignatti","year":"2006","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib26","first-page":"1420","article-title":"Risk factors for death in patients with beta-thalassemia major: results of a case-control study","volume":"91","author":"Ceci","year":"2006","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib27","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3324\/haematol.2009.009118","article-title":"Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone","volume":"94","author":"Telfer","year":"2009","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bcmd.2009.01.002","article-title":"Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies","volume":"42","author":"Maggio","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"10.1186\/1532-429X-13-45_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia","volume":"360","author":"Anderson","year":"2002","journal-title":"Lancet"},{"key":"10.1186\/1532-429X-13-45_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1182\/blood-2003-08-2841","article-title":"Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major","volume":"104","author":"Davis","year":"2004","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1053\/euhj.2000.2011","article-title":"Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance Are they interchangeable?","volume":"21","author":"Bellenger","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1186\/1532-429X-13-45_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","article-title":"Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia","volume":"10","author":"Velasco-S\u00e1nchez","year":"2011","journal-title":"Cerebellum"},{"key":"10.1186\/1532-429X-13-45_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2010.04.033","article-title":"Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload","volume":"49","author":"Gao","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1186\/1532-429X-13-45_bib34","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature09486","article-title":"The energetics of genome complexity","volume":"467","author":"Lane","year":"2010","journal-title":"Nature"},{"key":"10.1186\/1532-429X-13-45_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1186\/1532-429X-13-45_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","article-title":"Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles","volume":"551","author":"Garnier","year":"2003","journal-title":"J Physiol"},{"key":"10.1186\/1532-429X-13-45_bib37","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1152\/jappl.1992.73.6.2363","article-title":"Energy status of the rapidly paced canine myocardium in congestive heart failure","volume":"73","author":"Montgomery","year":"1992","journal-title":"J Appl Physiol"},{"key":"10.1186\/1532-429X-13-45_bib38","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.CIR.86.6.1810","article-title":"31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure","volume":"86","author":"Neubauer","year":"1992","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib39","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI116676","article-title":"Bioenergetic abnormalities associated with severe left ventricular hypertrophy","volume":"92","author":"Zhang","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1186\/1532-429X-13-45_bib40","doi-asserted-by":"crossref","first-page":"H1772","DOI":"10.1152\/ajpheart.00242.2007","article-title":"Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation","volume":"293","author":"Feygin","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1186\/1532-429X-13-45_bib41","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.RES.78.5.893","article-title":"Decreased energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance","volume":"78","author":"Liao","year":"1996","journal-title":"Circ Res"},{"key":"10.1186\/1532-429X-13-45_bib42","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.CIR.99.7.942","article-title":"Myocardial oxygenation during high work states in hearts with postinfarction remodeling","volume":"99","author":"Murakami","year":"1999","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib43","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.CIR.97.25.2536","article-title":"31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy","volume":"97","author":"Jung","year":"1998","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib44","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-2143(98)90148-2","article-title":"Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells","volume":"131","author":"Link","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1186\/1532-429X-13-45_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1998.tb10475.x","article-title":"Pathophysiology of Iron Overload","volume":"850","author":"Hershko","year":"2006","journal-title":"Ann NY Acad Sci"},{"key":"10.1186\/1532-429X-13-45_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.CIR.100.6.675","article-title":"Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes implications for the arrhythmogenesis of human siderotic heart disease","volume":"100","author":"Kuryshev","year":"1999","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib47","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1074\/jbc.M806235200","article-title":"Mitochondrial DNA damage in iron overload","volume":"284","author":"Gao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1186\/1532-429X-13-45_bib48","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1006\/jmcc.2001.1378","article-title":"Mitochondrial dysfunction in cardiac disease: ischemia\u2013reperfusion, aging, and heart failure","volume":"33","author":"Lesnefsky","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1186\/1532-429X-13-45_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0022-2143(98)90148-2","article-title":"Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells","volume":"131","author":"Link","year":"1998","journal-title":"J Lab Clin Med"},{"key":"10.1186\/1532-429X-13-45_bib50","series-title":"ATP and the heart","first-page":"16","author":"Ingwall","year":"2002"},{"key":"10.1186\/1532-429X-13-45_bib51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart-an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1186\/1532-429X-13-45_bib52","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.96.7.2190","article-title":"Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy","volume":"96","author":"Neubauer","year":"1997","journal-title":"Circulation"},{"key":"10.1186\/1532-429X-13-45_bib53","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0891-5849(02)00772-4","article-title":"Molecular bases of cellular iron toxicity","volume":"32","author":"Eaton","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1186\/1532-429X-13-45_bib54","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1172\/JCI118205","article-title":"Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation","volume":"96","author":"Kadiiska","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1186\/1532-429X-13-45_bib55","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0006-291X(80)90622-1","article-title":"Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid","volume":"93","author":"Fry","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1186\/1532-429X-13-45_bib56","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-291X(82)91976-3","article-title":"Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment","volume":"104","author":"Goormaghtigh","year":"1982","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1186\/1532-429X-13-45_bib57","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI114934","article-title":"Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload","volume":"86","author":"Houglum","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1186\/1532-429X-13-45_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0891-5849(90)90006-5","article-title":"Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences","volume":"9","author":"Stadtman","year":"1990","journal-title":"Free Radic Biol Med"},{"key":"10.1186\/1532-429X-13-45_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1172\/JCI118798","article-title":"Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase","volume":"98","author":"Pitkanen","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1186\/1532-429X-13-45_bib60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"10.1186\/1532-429X-13-45_bib61","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cvr\/cvm005","article-title":"Heart mitochondria: gates of life and death","volume":"77","author":"Gustafsson","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1186\/1532-429X-13-45_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.yjmcc.2010.07.002","article-title":"Optical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart","volume":"49","author":"Lyon","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1186\/1532-429X-13-45_bib63","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3324\/haematol.2010.032862","article-title":"Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial","volume":"96","author":"Wood","year":"2011","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib64","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1182\/blood-2008-06-161919","article-title":"Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation","volume":"112","author":"Kakhlon","year":"2008","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib65","first-page":"795","article-title":"Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective","volume":"3","author":"Galanello","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1186\/1532-429X-13-45_bib66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1124\/dmd.109.030833","article-title":"Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state","volume":"38","author":"Waldmeier","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"Suppl 1","key":"10.1186\/1532-429X-13-45_bib67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0037-1963(01)90061-7","article-title":"Deferoxamine pharmacokinetics","volume":"38","author":"Porter","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1186\/1532-429X-13-45_bib68","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1182\/blood.V86.5.2008.bloodjournal8652008","article-title":"Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo","volume":"86","author":"Shalev","year":"1995","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib69","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/lc.1999.v133.a94241","article-title":"Deferiprone therapy in homozygous human beta-thalassemia removes erythrocyte membrane free iron and reduces KCl cotransport activity","volume":"133","author":"De Franceschi","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1186\/1532-429X-13-45_bib70","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000243800","article-title":"Deferiprone chelation therapy for thalassemia major","volume":"122","author":"Galanello","year":"2009","journal-title":"Acta Haematol"},{"key":"10.1186\/1532-429X-13-45_bib71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3324\/haematol.2010.031468","article-title":"Continued improvement in myocardial T2* over 2 years of deferasirox therapy in beta-thalassemia major patients with cardiac iron overload","volume":"96","author":"Pennell","year":"2011","journal-title":"Haematologica"},{"key":"10.1186\/1532-429X-13-45_bib72","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V116.21.4276.4276","article-title":"Continued improvement and normalization of myocardial T2* in patients with \u03b2 thalassemia major treated with Deferasirox (Exjade\u00ae) for up to 3 years","volume":"116","author":"Pennell","year":"2010","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1182\/blood-2009-11-250308","article-title":"The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores","volume":"116","author":"Wood","year":"2010","journal-title":"Blood"},{"key":"10.1186\/1532-429X-13-45_bib74","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ajh.21830","article-title":"Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial","volume":"85","author":"Wood","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1186\/1532-429X-13-45_bib75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.1995.tb08927.x","article-title":"Iron chelators induce apoptosis in proliferating cells","volume":"89","author":"Hileti","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1186\/1532-429X-13-45_bib76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0008-8749(03)00031-5","article-title":"Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death","volume":"220","author":"Kim","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1186\/1532-429X-13-45_bib77","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0891-5849(03)00503-3","article-title":"Downregulation of p38 kinase pathway by cAMP response element-binding protein protects HL-60 cells from iron chelator-induced apoptosis","volume":"35","author":"Choi","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1186\/1532-429X-13-45_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12012-010-9068-9","article-title":"Deferasirox decreases age-associated iron accumulation in the aging F344XBN rat heart and liver","volume":"10","author":"Arvapalli","year":"2010","journal-title":"Cardiovasc Toxicol"},{"key":"10.1186\/1532-429X-13-45_bib79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1139\/Y09-128","article-title":"Ion redistribution as a therapeutic strategy for treating diseases of localized iron accumulation","volume":"88","author":"Kakhlon","year":"2010","journal-title":"Can Physiol Pharmacol"},{"key":"10.1186\/1532-429X-13-45_bib80","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1476-5381.2010.01120.x","article-title":"Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal","volume":"164","author":"Sohn","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1186\/1532-429X-13-45_bib81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10534-009-9281-9","article-title":"Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG","volume":"23","author":"Gaboriau","year":"2010","journal-title":"Biometals"},{"key":"10.1186\/1532-429X-13-45_bib82","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2141.2011.08626.x","article-title":"Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies","volume":"154","author":"Voskaridou","year":"2011","journal-title":"Br J Haematol"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1532-429X-13-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1532-429X-13-45\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109766472301400X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109766472301400X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1532-429X-13-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:08:05Z","timestamp":1761095285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109766472301400X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S109766472301400X"],"URL":"https:\/\/doi.org\/10.1186\/1532-429x-13-45","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/1532-429X-13-45","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"45"}}